Is Intuitive Surgical (ISRG) One of the Best Robotic Surgery Stocks to Buy?
Key takeaways
- Is Intuitive Surgical (ISRG) One of the Best Robotic Surgery Stocks to Buy?
- For additional reference, in its financial results for fiscal Q1, Intuitive Surgical, Inc.
- (NASDAQ:ISRG) has an elaborate ecosystem of services and products that provide robotic-assisted surgical solutions and invasive care.
Is Intuitive Surgical (ISRG) One of the Best Robotic Surgery Stocks to Buy? Noor Ul Ain Rehman Tue, May 26, 2026 at 7:09 PM GMT+7 2 min read ISRG Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best robotic surgery stocks to buy. Bof A cut the price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $520 from $650 on May 18, reiterating a Buy rating on the shares. The firm told investors that after having hosted 34 medtech companies the week before in Las Vegas, it updated several price targets for “the new reality of medtech valuations” in a year of few product cycles, inflation kicking up post-war, ACA and utilization worries, and “data centers over healthcare”.
For additional reference, in its financial results for fiscal Q1, Intuitive Surgical, Inc. (NASDAQ:ISRG) reported that worldwide procedures for da Vinci and Ion combined grew around 17% compared to fiscal Q1 2025, with Da Vinci procedures growing approximately 16%, and Ion procedures growing approximately 39%. Revenue for the quarter came up to $2.77 billion, up 23% compared to $2.25 billion in the prior year period. The company also reported that it placed 431 da Vinci surgical systems, compared with 367 in fiscal Q1 2025.
Intuitive Surgical, Inc. (NASDAQ:ISRG) has an elaborate ecosystem of services and products that provide robotic-assisted surgical solutions and invasive care. Its products include the Ion Endoluminal and the Da Vinci Surgical systems.